Dossier - Page 1 - FirstWord Reports

Learn More The Rise of ICER – The Payer Perspective

Payers reveal where ICER is really impacting pharma/payer relations How is the Institute for Clinical and Economic Review (ICER) influencing payer behavior? ICER's evidence and price benchmarking data are valued by...

Compare
Learn More Copy of Copy of The State of Pharma Digital Transformation 2020

Regional Purchase options: Germany United Kingdom UK How far has pharma come, and what does it still need to do, to realize the full benefits of digital technology across its business? The COVID-19...

Compare
Learn More Copy of The State of Pharma Digital Transformation 2020

Regional Purchase options: Germany United Kingdom UK How far has pharma come, and what does it still need to do, to realize the full benefits of digital technology across its business? The COVID-19...

Compare
Learn More The State of Pharma Digital Transformation 2020

How far has pharma come, and what does it still need to do, to realize the full benefits of digital technology across its business? The COVID-19 pandemic may have spurred rapid expansion in the use of digital tools but...

Compare
Learn More Telemedicine’s Move into the Mainstream

COVID-19 accelerated uptake of telemedicine is rapidly transforming healthcare delivery Telemedicine is one major success story of the pandemic. Barriers previously hindering widespread adoption of telehealth practices...

Compare
Learn More Smart Pharma Sales: How Digital is Reinventing the Process

Post COVID-19, pharma's opportunity is to build on the impact of digital technology to revolutionize its sales practice and engagement strategies The COVID-19 pandemic has radically reshaped how pharma does sales and...

Compare
Learn More Engaging with ICER: Lessons and insights for pharma

ICER is here to stay so how best can industry engage for its benefit? The Institute for Clinical and Economic Review (ICER) is gaining a growing reputation with US payers. While ICER's drug assessments are advisory, and...

Compare
Learn More Digital Health and the Management of Chronic Disease

Essential strategies for developing next phase digital health solutions The COVID-19 pandemic has accelerated and elevated the role of digital health and could serve as a turning point for digital platforms to become...

Compare
Learn More COVID-19 Implications for pharma: US payer insights

What are the implications for pharma as COVID-19 forces fundamental change in US payer practice and policy? The COVID-19 pandemic has created a unique set of challenges for US payers. In the short-term emergency...

Compare
Learn More Measuring Digital Success in Pharma: Essential KPIs

Which KPI's should pharma be using to assess the success of its digital technology investments? The Covid-19 pandemic is fundamentally changing working practice and driving immediate expansion of digital solutions. But...

Compare
Learn More Biosimilars: US Payer Insights 2020

What do payers see as unlocking the sluggish US biosimilar market? Despite the availability of biosimilar versions of Avastin, Herceptin and Rituxan, payers are not pleased with the development within this sector...

Compare
Learn More Digital Biomarkers: Pharma’s clinical development future?

Assessing digital biomarker applications that could radically impact pharma's clinical research practice By precisely and continuously measuring disease symptoms, digital biomarkers can allow pharma to establish valid...

Compare
Learn More Drivers of Non-medical Rx Switching

The strategies that are promoting wider use of biosimilars Payers are highly motivated to realise the cost savings of biosimilars, but what strategies are they using to reassure and encourage physicians and patients?...

Compare
Learn More The MSL Technology Survey (2020)

With physical distancing currently the norm, MSLs must radically change their working practice to effectively engage with KOLs Face-to-face meetings are the preferred choice of MSLs when sharing key scientific...

Compare
Learn More Trends in Digital Physician Engagement

Next level opportunities for developing physician relationships across pharma's business Digital technology has transformed pharma's communications with often difficult to engage physicians. But merely having a suite of...

Compare
Learn More Trends in Digital Patient Engagement

Embedding digital patient engagement throughout the patient journey Pharma companies have made good progress with digital delivery within innovative patient support programs—but there is still significant scope to...

Compare
Learn More Injectables and Implantables

Injectables and implantables are key to advancing patient centricity and adherence The development of controlled and prolonged release injectable and implantable drugs has seen huge leaps forward in recent years...

Compare
Learn More The Digitisation of Diabetes: Opportunities and Challenges for Industry

Assessing the revolutionary impact of digital technologies on the management of diabetes Advanced digital technologies and devices are driving fundamental change in the management of both Type 1 and 2...

Compare
Learn More Biosimilars: Go-to-Market Case Studies

As the biosimilar sector matures, what are the key issues that are shaping commercial strategies? As physician and payer confidence in the use of biosimilars grows, US and European companies are having to rethink their...

Compare
Learn More Digital Technologies: New Strategies for Customer Engagement

Digital technology is transforming customer engagement Pharma has embraced the digital revolution with open arms—clearly it offers exciting new opportunities for customer engagement. But initial enthusiasm...

Compare

Browse by